Procter & Gamble Q2 Sales Rise 1% to $22.2 B, EPS Falls 5%; Guidance Maintained
P&G’s Q2 fiscal 2026 net sales rose 1% to $22.2 billion with flat organic growth, diluted EPS fell 5% to $1.78 while core EPS stayed at $1.88. $5.0 billion operating cash flow funded $4.8 billion in dividends and buybacks, and 2026 sales growth guidance of 1–5% was maintained as EPS growth targets narrowed.
1. Fiscal Q2 Results Highlight Modest Top-Line Growth
Procter & Gamble reported net sales of $22.2 billion for the second quarter of fiscal 2026, up 1 percent versus the prior year. Organic sales, which strip out foreign exchange and transaction impacts, were flat as a 1 percent price increase was offset by a 1 percent decline in unit volumes. Diluted net earnings per share declined 5 percent to $1.78, driven primarily by incremental restructuring charges, while core earnings per share held steady at $1.88 compared with the prior year.
2. Strong Cash Generation and Shareholder Returns
Operating cash flow for the quarter reached $5.0 billion, and net earnings totaled $4.3 billion. Adjusted free cash flow productivity, defined as operating cash flow less capital spending divided by net earnings, was 88 percent. The company returned $4.8 billion to shareholders through $2.5 billion in dividends and $2.3 billion in share repurchases, underlining its commitment to balanced capital deployment.
3. Mixed Segment Performance Reflects Varied Consumer Demand
Organic sales growth varied across P&G’s five reportable segments. Beauty led with a 4 percent increase driven by mid-single-digit gains in Hair Care, Personal Care and low-single-digit growth in Skin Care, particularly in Latin America, Europe and Greater China. Health Care grew 3 percent, supported by premium Oral Care products and pricing in Personal Health Care. Grooming and Fabric & Home Care were unchanged year over year, as pricing gains offset volume declines in key regions. Baby, Feminine & Family Care declined 4 percent, reflecting weaker volumes and geographic mix challenges in Baby and Family Care.
4. Fiscal 2026 Outlook Balances Growth and Cost Pressures
P&G reaffirmed its full-year guidance, forecasting all-in sales growth of 1 to 5 percent and organic sales growth of 0 to 4 percent. Diluted net EPS is now expected to rise 1 to 6 percent, down from 3 to 9 percent previously, reflecting higher restructuring charges. Core EPS growth is maintained at 0 to 4 percent, implying a range of $6.83 to $7.09 per share. The company anticipates adjusted free cash flow productivity of 85 to 90 percent, with approximately $10 billion in dividend payments and $5 billion in share repurchases for the fiscal year.